Tag: medical cannabis

09
Jun

Co-Ops for Grow-Ops

As cannabis is still only legal in 22 states and the District of Columbia, federal banks have avoided dealing with cannabis businesses in order to stay out of federal courtrooms. This is one of the industry’s largest pitfalls; the lack of financial regulation, combined with the (now federally-recognized) tolerance of the industry, has fostered circumstances which leave much to the imagination about how cash is handled once transactions are complete.

The ultimate solution is still up for debate, however the first break for establishments in CO was signed into law by Governor John Hickenlooper on Friday: HB 1398. The bill allows for the formation of what it refers to as “marijuana financial service cooperatives” or “credit co-ops”. Dispensaries currently operating as cash-only businesses, suffer due to increased costs of business and risk for criminal activity (due to “large amounts of cash on the premises”).

(http://www.cbsnews.com/news/colorado-agrees-to-cannabis-credit-co-ops/)

07
Jun

Today in Cannabis

My Compassion, a nonprofit organization, prepares for the Chicago Cannabis Conference on Navy Pier this weekend. The first conference of its kind, speakers include: state representatives, doctors, lawyers, and industry professionals advocating the forward movement of responsibility and professionalism in a previously forbidden realm.

(http://www.chicagotribune.com/news/local/breaking/chi-cannabis-conference-at-navy-pier-this-weekend-20140606,0,981239.story)

The UK-based GW pharmaceuticals has announced plans to implement their product Epidiolex in US markets. Epidiolex is a cannabidiol (CBD) extract used to treat childhood epilepsy resulting from Dravet syndrome. Currently, Epidiolex is in use by only seven patients in the US under unique legal circumstances. As of today, the United States’ FDA has approved Epidiolex for “fast track designation”, which expedites the availability of breakthrough treatments.

(http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10880133/GW-Pharmaceuticals-cannabis-based-drug-Epidiolex-to-be-fast-tracked-in-US.html)

 

 

02
Jun

Today in Cannabis

For over a decade, synthetic “herbal incense” designed to mimic the effects of cannabis has gained popularity due to the fact it’s been buyable in-store, and doesn’t show up on drug tests. It’s dangerous because synthetic cannabanoids have the potential to be much more potent than their organic counterparts. In addition, their non-regulation leaves much unknown about potential negative effects.

The reason volatile ‘analogs’ (like various versions of herbal incense) even exist, is cannabis prohibition. If the federal government doesn’t make serious amendments to drug policy, significant demand for herbal incense will remain.

(http://www.ladybud.com/2014/06/02/inside-the-issue-synthetic-marijuana-aka-herbal-incense/)

01
Jun

Today in Cannabis

Republican Governor Terry Branstad signed a bill, the Medical Cannabidiol Act (SF 2360), allowing regulated CBD medications for children in Iowa. As the medical potential for CBD raises attention across the nation, parents in need of new options for their children are pressing lawmakers to get bills like the Medical Cannabidiol Act signed in their respective states.

Pictured above is Jayden David; he has a severe seizure-causing disorder called Dravet syndrome. His father was one of the first people to publicize this controversial, but ultimately life-saving, decision to treat his son with CBD oil extract. Their story has become synonymous with the success of CBD treatment, and can be followed on their Facebook page: Jason and Jayden’s Journey.

(http://www.desmoinesregister.com/story/news/politics/2014/05/31/branstad-cannabis-oil-extract-purchase-medical-marijuana-bill-sign/9803849/)